A Phase I trial to inform clinical protocols for the safe administration of psilocybin-assisted psychotherapy
medRxiv April 19, 2023 Jennifer Bennett, Michael D. Blough, Ian Mitchell et al. 3 citations preprint
Abstract This Phase I trial aims to inform the development of safety protocols for psilocybin-assisted therapy. Psychedelics, including psilocybin, are increasingly being recognized as a successful treatment option for many mental health concerns. In order to decrease the risks associated with its clinical use, more data is required regarding its physiological effects in healthy individuals....